FFO
DTIL icon

Fortitude Family Office’s Precision BioSciences DTIL Stock Holding History

Fortitude Family Office’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$998 Hold
127
– – ﹤0.01% 1755
2026
Q1 		$699 Buy
+127
New +$586 ﹤0.01% 1606
2025
Q3 		– Sell
-97
Closed -$407 – 2025
2025
Q2 		$407 Buy
+97
New +$479 ﹤0.01% 1879

Other funds holding DTIL

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CW
CrossGen Wealth Greenville, North Carolina $129M AUM
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
BFS
Beacon Financial Strategies Raleigh, North Carolina $201M AUM 19.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Fortitude Family Office's DTIL Position: Q2 2026 in Review

Fortitude Family Office held its Precision BioSciences (DTIL) position steady in Q2 2026 at 127 shares worth $998. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

Fortitude Family Office first reported a position in DTIL in Q2 2025 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Fortitude Family Office held 127 shares of Precision BioSciences worth $998 as of Q2 2026.
  • Fortitude Family Office left its Precision BioSciences share count unchanged in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1755 holding.
  • Fortitude Family Office first reported a position in Precision BioSciences in Q2 2025 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.